dc.contributor.author
Grunau, Anne
dc.contributor.author
Escher, Ulrike
dc.contributor.author
Kuehl, Anja A.
dc.contributor.author
Bereswill, Stefan
dc.contributor.author
Heimesaat, Markus M.
dc.date.accessioned
2018-06-08T10:42:19Z
dc.date.available
2017-12-22T10:22:44.305Z
dc.identifier.uri
https://refubium.fu-berlin.de/handle/fub188/20918
dc.identifier.uri
http://dx.doi.org/10.17169/refubium-24217
dc.description.abstract
Background Infections with multi-drug resistant (MDR) Gram-negative bacteria
including Pseudomonas aeruginosa (PA) have become a serious threat
particularly in hospitalized patients with immunopathological co-morbidities.
The well-balanced interplay between immune cells, pattern recognition
receptors such as Toll-like receptor (TLR)-4 sensing lipopolysaccharide from
Gram-negative bacteria including PA, and evolving pathways is crucial to
prevent the host from invading (opportunistic) pathogens. Information
regarding the molecular mechanisms underlying the interactions between
intestinal carriage of MDR PA and host immunity during chronic large
intestinal inflammation is scarce, however. Methods and results We therefore
perorally challenged conventionally colonized TLR4-deficient IL10−/− mice and
IL10−/− counterparts displaying comparably severe chronic colitis with a
clinical MDR PA strain. PA could more sufficiently establish in the intestinal
tract of TLR4-deficient IL10−/− mice until day 14 postinfection (p.i.),
whereas within 48 h the majority of IL10−/− mice had already expelled the
opportunistic pathogen from their guts. Intestinal colonization properties of
PA in TLR4-deficient IL10−/− mice were associated with distinct genotype-
dependent differences in gut microbiota compositions before challenge given
that TLR4-deficient IL10−/− mice harbored more fecal enterobacteria and
enterococci, but lower Clostridium/Eubacterium burdens. At day 14 p.i., PA-
induced increases in colonic immune cells such as macrophages, monocytes and
T-lymphocytes could be observed in TLR4-deficient IL10−/− mice, but not
IL10−/− counterparts, that were accompanied by a more distinct secretion of
IFN-γ in the colon and TNF in the mesenteric lymph nodes (MLN) of the former
as compared to the latter. Conversely, splenic TNF levels were lower in
TLR4-deficient IL10−/− mice as compared to IL10−/− controls at day 14 p.i.
Interestingly, more pronounced apoptotic responses could be assessed in
colonic epithelia of PA-challenged IL10−/− mice only. This was paralleled by
enhanced pro-inflammatory cytokine secretion not only in the intestines, but
also in extra-intestinal compartments of IL10−/− mice as indicated by
increased concentrations of nitric oxide in the colon, IFN-γ in the MLN and
IL-12p70 in the spleen at day 14 p.i. Conclusions Under chronic intestinal
inflammatory conditions including IL10−/− colitis MDR PA-association results
in well-orchestrated TLR4-dependent immune responses both in intestinal and
extra-intestinal compartments. Further studies should unravel the underlying
molecular mechanisms in more detail.
en
dc.rights.uri
http://creativecommons.org/licenses/by/4.0/
dc.subject
Pseudomonas aeruginosa
dc.subject
Multi-drug resistant Gram-negative bacteria
dc.subject
Colonization resistance
dc.subject
Susceptibility to infection
dc.subject
Intestinal microbiota shifts
dc.subject
Chronic IL10−/− colitis
dc.subject
Pro-inflammatory immune responses
dc.subject
Extra-intestinal sequelae of infection
dc.subject
Bacterial translocation
dc.subject
Toll-like receptor-4
dc.subject
Lipopolysaccharide
dc.subject.ddc
600 Technik, Medizin, angewandte Wissenschaften::610 Medizin und Gesundheit
dc.title
Toll-like receptor-4 differentially mediates intestinal and extra-intestinal
immune responses upon multi-drug resistant Pseudomonas aeruginosa association
of IL10−/− mice with chronic colitis
dc.type
Wissenschaftlicher Artikel
dcterms.bibliographicCitation
Gut Pathogens. - 9 (2017), Artikel Nr. 61
dcterms.bibliographicCitation.doi
10.1186/s13099-017-0211-z
dcterms.bibliographicCitation.url
http://doi.org/10.1186/s13099-017-0211-z
refubium.affiliation
Charité - Universitätsmedizin Berlin
de
refubium.mycore.fudocsId
FUDOCS_document_000000028700
refubium.note.author
Der Artikel wurde in einer reinen Open-Access-Zeitschrift publiziert.
refubium.resourceType.isindependentpub
no
refubium.mycore.derivateId
FUDOCS_derivate_000000009275
dcterms.accessRights.openaire
open access